Many peptide medications like glucagon-like peptide-1 (GLP-1) receptor agonists were initially developed to treat type 2 diabetes. One unexpected side effect of these drugs is weight loss.

GLP-1 receptor agonists like semaglutide were originally developed to boost insulin secretion, lower blood sugar, and support weight loss in people with type 2 diabetes. Researchers have since ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

Share on Pinterest Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight in the space of 6 months. Image credit: Tatsiana ...

GPL-1 agonists are used to treat diabetes and have become popular weight loss medications as well. They work by mimicking natural hormones your body produces, such as glucagon-like peptide (GLP-1 ...

choices for those with diabetes and who are vegan or vegetarian, the on-demand workouts and 24/7 support. Editor's note: Weight loss programs aren't recommended for those with a history of ...

recently said it needed to raise rates to offset increased expenses that included a surge in spending on weight loss drugs. Medicare covers the drugs for patients with diabetes, and a much smaller ...